There’s a lot at stake when it comes to understanding how AI is changing the economy at large. What’s the right outlook to have? Join Mat Honan, editor in chief, for a special conversation with David Rotman, editor at large, and Richard Waters, Financial Times columnist, exploring what’s happening across industries and the market. Going live on December…
Alex Blackwood was working as a real estate investing associate at Goldman Sachs. Here’s why he decided to start a business instead — despite the pay cut.
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology. The new company, called Preventive, is being formed to research so-called “heritable genome editing,” in which the DNA of embryos would be…